The R2D2-MH consortium is proud of the successful completion of its Second Reporting Period, marking an important step forward in the project’s mission to advance understanding of resilience and next-generation solutions for mental health and neurodivergence. This phase has been characterized by significant scientific progress, strengthened co-creation and collaboration among partners, and the consolidation of results that pave the way for upcoming activities.

Following the end of the Period, the consortium worked on the Periodic Report for RP2 to the European Commission, including a technical and a financial report. The progress have been discussed with the EU Project Officer and experts evaluators in a review meeting that took place on December 2, 2025. Reviewers shared positive feedback and constrictive comments to help the consortium implement the project at best in the remaining 24 months. Overall, the review confirmed that R2D2-MH is on the right track and well positioned to deliver its expected impacts in the upcoming phases.

The consortium remains committed to pushing the boundaries of research and innovation and to contributing to improved mental health outcomes across Europe through cutting-edge, data-informed solutions.